Metallothionein isoform II expression in hyperplastic, dysplastic and neoplastic prostatic lesions
- PMID: 16574721
- PMCID: PMC1860510
- DOI: 10.1136/jcp.2005.033746
Metallothionein isoform II expression in hyperplastic, dysplastic and neoplastic prostatic lesions
Abstract
Background: Metallothionein is a low-molecular-weight cysteine-rich protein that has the ability to bind and sequestrate heavy metal ions. It is associated with metalloregulatory functions such as cell proliferation, growth and differentiation.
Aims: To investigate the expression of metallothionein in hyperplastic, dysplastic and neoplastic prostatic lesions and to correlate its expression with histological grade of prostatic carcinoma.
Method: The study was carried out on formalin-fixed and paraffin-wax-embedded tissue blocks from 8 patients with benign prostatic hyperplasia, 6 patients with prostatic intraepithelial neoplasia (PIN) and 30 patients with prostatic carcinoma, using the streptavidin-biotin technique. The histological grade was defined and the carcinomas were divided into low-grade (Gleason Score 2-4), 12 moderate grade (Gleason Score 5-6) and 10 high-grade (Gleason Score 7-10) carcinomas.
Results: Patchy metallothionein staining of epithelial cells was observed in normal and benign prostatic tissues. All cases of PIN and 20 of 30 patients with prostatic carcinoma showed positive staining for metallothionein. Metallothionein expression considerably increased from low-grade to high-grade tumours. The proportion of cells staining positively for metallothionein was directly correlated with histological grade of prostatic carcinoma. The epithelial cells lack uniformity in staining intensity, but the percentage of strongly positive cells increased with the histological grade of prostatic carcinoma.
Conclusions: The high incidence of metallothionein expression in PIN in our study suggests that it is associated with early prostate tumorigenesis. Also, metallothionein expression was directly correlated with the histological grade of prostatic carcinoma, suggesting that metallothionein may be a useful marker for predicting the prognosis of prostate cancer.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer.Exp Mol Pathol. 2004 Oct;77(2):153-9. doi: 10.1016/j.yexmp.2004.04.005. Exp Mol Pathol. 2004. PMID: 15351240 Clinical Trial.
-
Nucleolar and AgNOR-analysis of prostatic intraepithelial neoplasia (PIN), atypical adenomatous hyperplasia (AAH) and prostatic carcinoma.Pathol Res Pract. 1995 Jun;191(5):381-90. doi: 10.1016/S0344-0338(11)80723-5. Pathol Res Pract. 1995. PMID: 7479355
-
Prostate cancer antigen-1 as a potential novel marker for prostate cancer.Asian J Androl. 2007 Nov;9(6):821-6. doi: 10.1111/j.1745-7262.2007.00279.x. Asian J Androl. 2007. PMID: 17968469
-
Prospective origins of prostate carcinoma. Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia.Cancer. 1996 Jul 15;78(2):330-6. doi: 10.1002/(SICI)1097-0142(19960715)78:2<330::AID-CNCR22>3.0.CO;2-W. Cancer. 1996. PMID: 8674012 Review.
-
Natural history of prostatic carcinoma: the pathologist's perspective.Recent Results Cancer Res. 2007;175:9-24. doi: 10.1007/978-3-540-40901-4_2. Recent Results Cancer Res. 2007. PMID: 17432551 Review.
Cited by
-
Metallothionein - immunohistochemical cancer biomarker: a meta-analysis.PLoS One. 2014 Jan 8;9(1):e85346. doi: 10.1371/journal.pone.0085346. eCollection 2014. PLoS One. 2014. PMID: 24416395 Free PMC article.
-
Metallothionein Lower Under-Expression in Benign Tumors than That in Malignant Tumors: Systematic Review Article and Meta-Analysis.Iran J Public Health. 2014 Jun;43(6):696-704. Iran J Public Health. 2014. PMID: 26110140 Free PMC article. Review.
-
Differential expression of metallothioneins (MTs) 1, 2, and 3 in response to zinc treatment in human prostate normal and malignant cells and tissues.Mol Cancer. 2008 Jan 21;7:7. doi: 10.1186/1476-4598-7-7. Mol Cancer. 2008. PMID: 18208603 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical